Verification of ALDH Activity as a Biomarker in Colon Cancer Stem Cells-Derived HT-29 Cell Line
Recent evidence has suggested that epithelial cancers including colorectal cancer (CRC) have driven by a small population of self-renewing, multi-potent cells termed cancer stem cells (CSCs) which could be responsible for recurrence of cancer. Aldehyde dehydrogenase 1 (ALDH1) activity has used as a...
Saved in:
Published in | Iranian journal of cancer prevention Vol. 8; no. 5; p. e3446 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
Iran
Shahid Beheshti University of Medical Sciences
01.10.2015
|
Subjects | |
Online Access | Get full text |
ISSN | 2008-2398 2008-2401 |
DOI | 10.17795/ijcp-3446 |
Cover
Abstract | Recent evidence has suggested that epithelial cancers including colorectal cancer (CRC) have driven by a small population of self-renewing, multi-potent cells termed cancer stem cells (CSCs) which could be responsible for recurrence of cancer. Aldehyde dehydrogenase 1 (ALDH1) activity has used as a functional stem cell biomarker to isolate CSCs in different cancers such as colorectal cancer.
The main aim of this research was to determine the utility of ALDH1 activity along with CD44 and EPCAM in identifying stem cell-like cells in human HT-29 colonic adenocarcinoma cell line.
In this experimental study, colon CSCs biomarkers including CD44, EPCAM and ALDH1 in colonospheres and parent cells have analyzed by flow cytometry. The expression levels of stemness genes in spheroid and parental cells have investigated using SYBR Green real-time PCR. In addition, in vivo xenografts assay has performed to determine tumorigenic potential of tumor spheroid cells in nude mice.
According to results, over 92% of spheroids were CD44+/EpCAM+, while parent cells only have expressed 38% of CD44/EpCAM biomarkers (P < 0.001). Controversially, ALDH activity was about 2-fold higher in the parent cells than spheroid cells (P < 0.05). In comparison with the parental cells, expression levels of ''stemness'' genes, like Sox2, Oct4, Nanog, C-myc, and Klf4 have significantly increased in colonosphere cells (P < 0.05). Further, administration of 2500 spheroids could be sufficient to initiate tumor growth in nude mice, while 1x106 of parental cells has needed to form tumor.
For the first time, we have shown that colonospheres with low ALDH1 activity has indicated increased tumorigenic potential and stemness properties. So, it hasn't seemed that ALDH1 could become a useful biomarker to identify CSCs population in HT-29 cell line. |
---|---|
AbstractList | BACKGROUNDRecent evidence has suggested that epithelial cancers including colorectal cancer (CRC) have driven by a small population of self-renewing, multi-potent cells termed cancer stem cells (CSCs) which could be responsible for recurrence of cancer. Aldehyde dehydrogenase 1 (ALDH1) activity has used as a functional stem cell biomarker to isolate CSCs in different cancers such as colorectal cancer.OBJECTIVESThe main aim of this research was to determine the utility of ALDH1 activity along with CD44 and EPCAM in identifying stem cell-like cells in human HT-29 colonic adenocarcinoma cell line.MATERIALS AND METHODSIn this experimental study, colon CSCs biomarkers including CD44, EPCAM and ALDH1 in colonospheres and parent cells have analyzed by flow cytometry. The expression levels of stemness genes in spheroid and parental cells have investigated using SYBR Green real-time PCR. In addition, in vivo xenografts assay has performed to determine tumorigenic potential of tumor spheroid cells in nude mice.RESULTSAccording to results, over 92% of spheroids were CD44+/EpCAM+, while parent cells only have expressed 38% of CD44/EpCAM biomarkers (P < 0.001). Controversially, ALDH activity was about 2-fold higher in the parent cells than spheroid cells (P < 0.05). In comparison with the parental cells, expression levels of ''stemness'' genes, like Sox2, Oct4, Nanog, C-myc, and Klf4 have significantly increased in colonosphere cells (P < 0.05). Further, administration of 2500 spheroids could be sufficient to initiate tumor growth in nude mice, while 1x106 of parental cells has needed to form tumor.CONCLUSIONSFor the first time, we have shown that colonospheres with low ALDH1 activity has indicated increased tumorigenic potential and stemness properties. So, it hasn't seemed that ALDH1 could become a useful biomarker to identify CSCs population in HT-29 cell line. Recent evidence has suggested that epithelial cancers including colorectal cancer (CRC) have driven by a small population of self-renewing, multi-potent cells termed cancer stem cells (CSCs) which could be responsible for recurrence of cancer. Aldehyde dehydrogenase 1 (ALDH1) activity has used as a functional stem cell biomarker to isolate CSCs in different cancers such as colorectal cancer. The main aim of this research was to determine the utility of ALDH1 activity along with CD44 and EPCAM in identifying stem cell-like cells in human HT-29 colonic adenocarcinoma cell line. In this experimental study, colon CSCs biomarkers including CD44, EPCAM and ALDH1 in colonospheres and parent cells have analyzed by flow cytometry. The expression levels of stemness genes in spheroid and parental cells have investigated using SYBR Green real-time PCR. In addition, in vivo xenografts assay has performed to determine tumorigenic potential of tumor spheroid cells in nude mice. According to results, over 92% of spheroids were CD44+/EpCAM+, while parent cells only have expressed 38% of CD44/EpCAM biomarkers (P < 0.001). Controversially, ALDH activity was about 2-fold higher in the parent cells than spheroid cells (P < 0.05). In comparison with the parental cells, expression levels of ''stemness'' genes, like Sox2, Oct4, Nanog, C-myc, and Klf4 have significantly increased in colonosphere cells (P < 0.05). Further, administration of 2500 spheroids could be sufficient to initiate tumor growth in nude mice, while 1x106 of parental cells has needed to form tumor. For the first time, we have shown that colonospheres with low ALDH1 activity has indicated increased tumorigenic potential and stemness properties. So, it hasn't seemed that ALDH1 could become a useful biomarker to identify CSCs population in HT-29 cell line. |
Author | Zavaran Hosseini, Ahmad Khorrami, Samaneh Mowla, Seyed Javad Malekzadeh, Reza |
AuthorAffiliation | 1 Department of Immunology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, IR Iran 2 Department of Molecular Genetics, Faculty of Biological Sciences , Tarbiat Modares University, Tehran, IR Iran 3 Digestive Oncology Research Center, Digestive Diseases Research Institute, Tehran University of Medical Sciences, Tehran, IR Iran |
AuthorAffiliation_xml | – name: 2 Department of Molecular Genetics, Faculty of Biological Sciences , Tarbiat Modares University, Tehran, IR Iran – name: 3 Digestive Oncology Research Center, Digestive Diseases Research Institute, Tehran University of Medical Sciences, Tehran, IR Iran – name: 1 Department of Immunology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, IR Iran |
Author_xml | – sequence: 1 givenname: Samaneh surname: Khorrami fullname: Khorrami, Samaneh – sequence: 2 givenname: Ahmad surname: Zavaran Hosseini fullname: Zavaran Hosseini, Ahmad – sequence: 3 givenname: Seyed Javad surname: Mowla fullname: Mowla, Seyed Javad – sequence: 4 givenname: Reza surname: Malekzadeh fullname: Malekzadeh, Reza |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/26634106$$D View this record in MEDLINE/PubMed |
BookMark | eNptkctOAyEUhonReN_4AIalMRmFgeGyManjpSZNXFjdEsqAolOow7SJby_WatTIhsv5zn_O4d8B6yEGC8ABRieYc1md-mczKwilbA1slwiJoqQIr3-diRRbYD-lZ5QXIVggvAm2SsYIxYhtA_VgO--80b2PAUYHB6OLIRyY3i98_wZ1ghqe-zjV3YvtoA-wjm0Gax1Mvt_1dgpr27apuMg6C9vA4bgo5fINjnywe2DD6TbZ_dW-C-6vLsf1sBjdXt_Ug1FhKKV90VjDGymxLZ2sMMXYUi4cLo10gjtW8coxwSciBysiOW2aSmBqJiQPyCiqyC44-9SdzSdT2xgb-k63atb53Pqbitqr35Hgn9RjXCjKGC8JzQJHK4Euvs5t6tXUJ5PH0MHGeVKYU8kQ4ZXI6OHPWt9Fvn41A8efgOliSp113whGauma-nBNfbiWYfQHNr5f2pH79O1_Ke812pgV |
CitedBy_id | crossref_primary_10_1016_j_phymed_2021_153484 crossref_primary_10_2174_1574888X13666180810120012 crossref_primary_10_1021_acs_analchem_1c02316 crossref_primary_10_1002_jcp_28132 crossref_primary_10_2174_0113816128291321240329050945 crossref_primary_10_1007_s12032_021_01488_9 crossref_primary_10_1016_j_semcancer_2023_01_001 crossref_primary_10_1016_j_bbrc_2021_12_089 crossref_primary_10_3389_fcell_2023_1231416 crossref_primary_10_1002_jcp_25318 crossref_primary_10_3892_etm_2017_4846 crossref_primary_10_1016_j_prp_2019_03_008 crossref_primary_10_2217_fon_2017_0091 crossref_primary_10_1002_biof_70002 crossref_primary_10_23868_201808016 crossref_primary_10_3390_molecules24244520 crossref_primary_10_3892_or_2016_5120 crossref_primary_10_5812_ijcm_5700 crossref_primary_10_1002_iub_2166 |
Cites_doi | 10.2174/157488808786734006 10.1073/pnas.0805706105 10.1038/nature05384 10.1158/0008-5472.CAN-06-3281 10.3390/cancers30100716 10.1245/s10434-009-0567-5 10.1016/j.stem.2007.08.014 10.1016/j.jim.2009.06.008 10.1038/35102167 10.1136/jcp.2004.016238 10.1073/pnas.0703478104 10.1245/s10434-009-0617-z 10.1371/journal.pone.0010731 10.1158/0008-5472.CAN-08-4418 10.1186/1471-2407-12-42 10.1186/1476-4598-9-212 10.1002/stem.1170 10.1038/nature05372 10.1016/j.canlet.2009.02.033 10.1093/jnci/djj495 10.1158/0008-5472.CAN-04-0328 10.1002/ijc.24061 10.1016/j.stem.2007.10.015 |
ContentType | Journal Article |
Copyright | Copyright © 2015, Iranian Journal of Cancer Prevention. 2015 |
Copyright_xml | – notice: Copyright © 2015, Iranian Journal of Cancer Prevention. 2015 |
DBID | AAYXX CITATION NPM 7X8 5PM |
DOI | 10.17795/ijcp-3446 |
DatabaseName | CrossRef PubMed MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic PubMed |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 2008-2401 |
EndPage | e3446 |
ExternalDocumentID | PMC4667234 26634106 10_17795_ijcp_3446 |
Genre | Journal Article |
GroupedDBID | 04C 53G AAWTL AAYXX ADBBV ADRAZ ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BMSDO CITATION C~G DIK DYU EBD EIHBH HYE KQ8 M48 OK1 PGMZT RNS RPM NPM 7X8 5PM |
ID | FETCH-LOGICAL-c444t-dec7d991e2f951411e478f12c9f87f6575f687b895153974dd5814cb323964053 |
IEDL.DBID | M48 |
ISSN | 2008-2398 |
IngestDate | Thu Aug 21 17:47:10 EDT 2025 Thu Jul 10 22:23:23 EDT 2025 Mon Jul 21 06:01:15 EDT 2025 Wed Aug 27 16:27:18 EDT 2025 Thu Apr 24 23:10:45 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | true |
Issue | 5 |
Keywords | Colorectal Cancer ALDH Biomarker Cancer Stem Cell HT-29 |
Language | English |
License | This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c444t-dec7d991e2f951411e478f12c9f87f6575f687b895153974dd5814cb323964053 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.17795/ijcp-3446 |
PMID | 26634106 |
PQID | 1749603758 |
PQPubID | 23479 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_4667234 proquest_miscellaneous_1749603758 pubmed_primary_26634106 crossref_primary_10_17795_ijcp_3446 crossref_citationtrail_10_17795_ijcp_3446 |
PublicationCentury | 2000 |
PublicationDate | 2015-10-01 |
PublicationDateYYYYMMDD | 2015-10-01 |
PublicationDate_xml | – month: 10 year: 2015 text: 2015-10-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | Iran |
PublicationPlace_xml | – name: Iran |
PublicationTitle | Iranian journal of cancer prevention |
PublicationTitleAlternate | Iran J Cancer Prev |
PublicationYear | 2015 |
Publisher | Shahid Beheshti University of Medical Sciences |
Publisher_xml | – name: Shahid Beheshti University of Medical Sciences |
References | key-A3446REF25-25 key-A3446REF12-12 key-A3446REF14-14 key-A3446REF16-16 Moreb JS (key-A3446REF15-15) 2008; 3 key-A3446REF9-9 key-A3446REF8-8 key-A3446REF7-7 key-A3446REF6-6 key-A3446REF21-21 Yu C (key-A3446REF24-24) 2011; 25 key-A3446REF5-5 key-A3446REF23-23 key-A3446REF4-4 key-A3446REF3-3 key-A3446REF2-2 key-A3446REF1-1 Willson JK (key-A3446REF18-18) 1987; 47 key-A3446REF10-10 key-A3446REF11-11 key-A3446REF13-13 key-A3446REF17-17 key-A3446REF19-19 key-A3446REF20-20 key-A3446REF22-22 18938743 - Cell Stem Cell. 2007 Nov;1(5):485-7 17122772 - Nature. 2007 Jan 4;445(7123):106-10 17548814 - Proc Natl Acad Sci U S A. 2007 Jun 12;104(24):10158-63 18371393 - Cell Stem Cell. 2007 Nov;1(5):555-67 22280212 - BMC Cancer. 2012 Jan 26;12:42 17332349 - Cancer Res. 2007 Mar 1;67(5):2187-96 3567899 - Cancer Res. 1987 May 15;47(10):2704-13 19657699 - Ann Surg Oncol. 2009 Dec;16(12 ):3488-98 19336570 - Cancer Res. 2009 Apr 15;69(8):3382-9 15256451 - Cancer Res. 2004 Jul 15;64(14):4817-25 18765800 - Proc Natl Acad Sci U S A. 2008 Sep 9;105(36):13427-32 21282737 - In Vivo. 2011 Jan-Feb;25(1):69-76 20691072 - Mol Cancer. 2010 Aug 06;9:212 20505780 - PLoS One. 2010 May 20;5(5):e10731 11689955 - Nature. 2001 Nov 1;414(6859):105-11 19324493 - Cancer Lett. 2009 Aug 18;281(1):92-9 21643534 - Cancers (Basel). 2011 Feb 21;3(1):716-29 19554373 - Ann Surg Oncol. 2009 Sep;16(9):2638-44 22782858 - Stem Cells. 2012 Sep;30(9):1831-41 19567251 - J Immunol Methods. 2009 Aug 15;347(1-2):70-8 17122771 - Nature. 2007 Jan 4;445(7123):111-5 17179479 - J Natl Cancer Inst. 2006 Dec 20;98 (24):1777-85 19072981 - Int J Cancer. 2009 Mar 15;124(6):1312-21 15509676 - J Clin Pathol. 2004 Nov;57(11):1160-4 19075754 - Curr Stem Cell Res Ther. 2008 Dec;3(4):237-46 |
References_xml | – volume: 3 start-page: 237 issue: 4 year: 2008 ident: key-A3446REF15-15 publication-title: Curr Stem Cell Res Ther. doi: 10.2174/157488808786734006 – ident: key-A3446REF7-7 doi: 10.1073/pnas.0805706105 – ident: key-A3446REF2-2 doi: 10.1038/nature05384 – ident: key-A3446REF13-13 doi: 10.1158/0008-5472.CAN-06-3281 – ident: key-A3446REF8-8 doi: 10.3390/cancers30100716 – ident: key-A3446REF10-10 doi: 10.1245/s10434-009-0567-5 – ident: key-A3446REF12-12 doi: 10.1016/j.stem.2007.08.014 – ident: key-A3446REF20-20 doi: 10.1016/j.jim.2009.06.008 – ident: key-A3446REF1-1 doi: 10.1038/35102167 – ident: key-A3446REF6-6 doi: 10.1136/jcp.2004.016238 – ident: key-A3446REF4-4 doi: 10.1073/pnas.0703478104 – volume: 47 start-page: 2704 issue: 10 year: 1987 ident: key-A3446REF18-18 publication-title: Cancer Res. – ident: key-A3446REF9-9 doi: 10.1245/s10434-009-0617-z – ident: key-A3446REF25-25 doi: 10.1371/journal.pone.0010731 – ident: key-A3446REF16-16 doi: 10.1158/0008-5472.CAN-08-4418 – ident: key-A3446REF11-11 doi: 10.1186/1471-2407-12-42 – ident: key-A3446REF19-19 doi: 10.1186/1476-4598-9-212 – ident: key-A3446REF23-23 doi: 10.1002/stem.1170 – ident: key-A3446REF3-3 doi: 10.1038/nature05372 – ident: key-A3446REF21-21 doi: 10.1016/j.canlet.2009.02.033 – ident: key-A3446REF22-22 doi: 10.1093/jnci/djj495 – ident: key-A3446REF17-17 doi: 10.1158/0008-5472.CAN-04-0328 – volume: 25 start-page: 69 issue: 1 year: 2011 ident: key-A3446REF24-24 publication-title: In Vivo. – ident: key-A3446REF5-5 doi: 10.1002/ijc.24061 – ident: key-A3446REF14-14 doi: 10.1016/j.stem.2007.10.015 – reference: 15509676 - J Clin Pathol. 2004 Nov;57(11):1160-4 – reference: 20691072 - Mol Cancer. 2010 Aug 06;9:212 – reference: 19657699 - Ann Surg Oncol. 2009 Dec;16(12 ):3488-98 – reference: 17122771 - Nature. 2007 Jan 4;445(7123):111-5 – reference: 21643534 - Cancers (Basel). 2011 Feb 21;3(1):716-29 – reference: 17179479 - J Natl Cancer Inst. 2006 Dec 20;98 (24):1777-85 – reference: 18371393 - Cell Stem Cell. 2007 Nov;1(5):555-67 – reference: 15256451 - Cancer Res. 2004 Jul 15;64(14):4817-25 – reference: 22280212 - BMC Cancer. 2012 Jan 26;12:42 – reference: 17122772 - Nature. 2007 Jan 4;445(7123):106-10 – reference: 17548814 - Proc Natl Acad Sci U S A. 2007 Jun 12;104(24):10158-63 – reference: 19567251 - J Immunol Methods. 2009 Aug 15;347(1-2):70-8 – reference: 17332349 - Cancer Res. 2007 Mar 1;67(5):2187-96 – reference: 11689955 - Nature. 2001 Nov 1;414(6859):105-11 – reference: 19336570 - Cancer Res. 2009 Apr 15;69(8):3382-9 – reference: 19324493 - Cancer Lett. 2009 Aug 18;281(1):92-9 – reference: 19554373 - Ann Surg Oncol. 2009 Sep;16(9):2638-44 – reference: 19075754 - Curr Stem Cell Res Ther. 2008 Dec;3(4):237-46 – reference: 22782858 - Stem Cells. 2012 Sep;30(9):1831-41 – reference: 18938743 - Cell Stem Cell. 2007 Nov;1(5):485-7 – reference: 18765800 - Proc Natl Acad Sci U S A. 2008 Sep 9;105(36):13427-32 – reference: 20505780 - PLoS One. 2010 May 20;5(5):e10731 – reference: 19072981 - Int J Cancer. 2009 Mar 15;124(6):1312-21 – reference: 21282737 - In Vivo. 2011 Jan-Feb;25(1):69-76 – reference: 3567899 - Cancer Res. 1987 May 15;47(10):2704-13 |
SSID | ssj0000331801 |
Score | 2.137591 |
Snippet | Recent evidence has suggested that epithelial cancers including colorectal cancer (CRC) have driven by a small population of self-renewing, multi-potent cells... BACKGROUNDRecent evidence has suggested that epithelial cancers including colorectal cancer (CRC) have driven by a small population of self-renewing,... |
SourceID | pubmedcentral proquest pubmed crossref |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | e3446 |
Title | Verification of ALDH Activity as a Biomarker in Colon Cancer Stem Cells-Derived HT-29 Cell Line |
URI | https://www.ncbi.nlm.nih.gov/pubmed/26634106 https://www.proquest.com/docview/1749603758 https://pubmed.ncbi.nlm.nih.gov/PMC4667234 |
Volume | 8 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
journalDatabaseRights | – providerCode: PRVCAB databaseName: Nutrition and Food Sciences Database customDbUrl: eissn: 2008-2401 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000331801 issn: 2008-2398 databaseCode: DYU dateStart: 20090101 isFulltext: true titleUrlDefault: https://www.cabidigitallibrary.org/product/zd providerName: CAB International – providerCode: PRVAFT databaseName: Open Access Digital Library customDbUrl: eissn: 2008-2401 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000331801 issn: 2008-2398 databaseCode: KQ8 dateStart: 20110101 isFulltext: true titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html providerName: Colorado Alliance of Research Libraries – providerCode: PRVBFR databaseName: Free Medical Journals customDbUrl: eissn: 2008-2401 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000331801 issn: 2008-2398 databaseCode: DIK dateStart: 20080101 isFulltext: true titleUrlDefault: http://www.freemedicaljournals.com providerName: Flying Publisher – providerCode: PRVAQN databaseName: PubMed Central customDbUrl: eissn: 2008-2401 dateEnd: 20161231 omitProxy: true ssIdentifier: ssj0000331801 issn: 2008-2398 databaseCode: RPM dateStart: 20110101 isFulltext: true titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/ providerName: National Library of Medicine – providerCode: PRVFZP databaseName: Scholars Portal Journals: Open Access customDbUrl: eissn: 2008-2401 dateEnd: 20160630 omitProxy: true ssIdentifier: ssj0000331801 issn: 2008-2398 databaseCode: M48 dateStart: 20110101 isFulltext: true titleUrlDefault: http://journals.scholarsportal.info providerName: Scholars Portal |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV07T8MwELZ4SIgF8aa8ZAQLgyGJ7dgZECoFVCHKAkVskeOHKCoptAXBv-ecpBUFBpYM8dmK7s6-78tZdwgdaG6UCAwnKuGGMGozoqhxxLgw0cYmimeeKLZu4mabXT3whyk06t9ZKXDwJ7Xz_aTa_e7Rx-vnKWz4E7_hhUj4cedJvxAKxGYazUJEirx3tyqYX5zIFDy36IRcZPt9ybuqUunk9MnY9Atw_rw3-S0QXS6ihQpB4npp8iU0ZfNlNNeqcuQrKL0Hp3LVrzjcc7h-fd7EdV22icBqgBU-6_Se_b2cPu7kuAHnHzy9-fv4dmifccN2uwNyDuu8W4ObdyRKincYmKtdRe3Li7tGk1RtFIhmjA2JsVoYgIE2cgCnWBhaJqQLI504KZxPvLhYikzCIAd0wozhMmQ6o6CnGPAcXUMzeS-3GwgnmkmjpDWOOsaDIAupkYFUzilrE85q6HCkwFRXNcZ9q4tu6rmGV3bqlZ16ZdfQ_lj2pays8afU3sgOKTi-z2ao3PbeBiDIgH1R4Ds1tF7aZbwOoA6IzgHMFhMWGwv4otqTI3nnsSiuzeJYRJRt_uvrttA8ACheXu7bRjPD_pvdAZAyzHYLD_wCFZvmBQ |
linkProvider | Scholars Portal |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Verification+of+ALDH+Activity+as+a+Biomarker+in+Colon+Cancer+Stem+Cells-Derived+HT-29+Cell+Line&rft.jtitle=Iranian+journal+of+cancer+prevention&rft.au=Khorrami%2C+Samaneh&rft.au=Zavaran+Hosseini%2C+Ahmad&rft.au=Mowla%2C+Seyed+Javad&rft.au=Malekzadeh%2C+Reza&rft.date=2015-10-01&rft.issn=2008-2398&rft.eissn=2008-2401&rft.volume=8&rft.issue=5&rft_id=info:doi/10.17795%2Fijcp-3446&rft.externalDBID=n%2Fa&rft.externalDocID=10_17795_ijcp_3446 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2008-2398&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2008-2398&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2008-2398&client=summon |